Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination dietary supplement containing lipoic acid (also known as alpha-lipoic acid or thioctic acid) and fish oil concentrate (a source of omega-3 polyunsaturated fatty acids, primarily EPA and DHA). Lipoic acid acts as a potent antioxidant and mitochondrial cofactor involved in energy metabolism, while also exhibiting chelating properties for heavy metals. Fish oil provides essential omega-3 fatty acids that modulate lipid metabolism and have anti-inflammatory effects. The combination has been studied for additive or synergistic effects on reducing serum lipid levels by down-regulating hepatic lipogenesis, improving antioxidant status, and potentially slowing cognitive decline in conditions such as Alzheimer's disease. Lipoic acid may attenuate oxidative stress associated with fish oil supplementation[1][2][3]. This product is typically used as a dietary supplement rather than a pharmaceutical drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lipoic acid + fish oil concentrate.